Health Canada must step-up consumer warnings on the risks of common acid-reducing prescription medications amid “unconscionable” delays, says a Conservative MP. The warnings concern one of the most popularly-prescribed class of drugs: “There is no question of the danger”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
